10x Genomics, Inc. Class A Common Stock (TXG) is a publicly traded Healthcare sector company. As of September 1, 2026, TXG trades at $62.19 with a market cap of $8.02B and a P/E ratio of -104.45. TXG moved +1.38% today. Year to date, TXG is +282.89%; over the trailing twelve months it is +345.75%. Its 52-week range spans $6.78 to $66.94. Analyst consensus is buy with an average price target of $50.36. Rallies surfaces TXG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest TXG news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $62.19 |
| Market Cap | $8.02B |
| P/E Ratio | -104.45 |
| EPS | $-0.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $66.94 |
| 52-Week Low | $6.78 |
| Volume | 1.95M |
| Avg Volume | 0 |
| Revenue (TTM) | $616.91M |
| Net Income | $-75.13M |
| Gross Margin | 70.03% |
13 analysts cover TXG: 0 strong buy, 6 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $50.36.